A new drug compound which could tackle major life-limiting kidney disease has been developed by researchers @ShefUni_IICD as part of an international collaboration.
https://t.co/UB04OkAC8w
Happy to announce our latest paper!
We show that a small C-terminal product of FPC localises to mitochondria and functions to protect against renal cystogenesis.
Thanks so much to everyone involved!
https://t.co/Mr5dcEHRvu
Exciting and demanding @goKDIGO meeting to provide guidance for #adpkd.
Great great team!!
Amazing team-work, especially the chairs #torres and #devuyst!! Huge thanks to @goKDIGO staff!! Special mention to smart @Reem_A_Mustafa
🔥New paper highlights importance of genetic testing in CKD pts when etiology is not certain
Presentation non-specific: Non-proteinuria CKD, HTN, no gout, +FH, Bx mostly shows IFTA
How many such patients have 🫵 seen in clinic⁉️
We identified 41 pedigrees with the UMOD variant across regional centres and national databases.
This study provides evidence for a pathogenic ancestral variant prevalent in the British population that is responsible for kidney failure and chronic kidney disease.
Delighted to share our recent publication.
A founder UMOD variant is a common cause of hereditary nephropathy in the British population.
Thank you to all who helped with this work!
@mkvalluru
https://t.co/wgnQz4ThbP
The 2nd project funded as part of our partnership with @Kidney_Research is that of Professor Albert Ong, who is on a mission to better understand PKD cyst formation - Potentially a major step towards finding a cure for ADPKD!
Read more 👉 https://t.co/TH4tO19hE6
@Ong_Lab
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know & what we don’t
👉we should be cautious in recommending KDI or ketone supplementation despite encouraging preclinical findings
📸Dietary modifications in PKD rodent models
https://t.co/wE3EOQwvp9
Don't forget to register for our next 'Driving discoveries' virtual event next week!
Hear from Dr Maria Fragiadaki, who will present her work unlocking the ADPKD mechanism to provide hope of new medicines for people affected with ADPKD.
Register now 👉 https://t.co/0W5ku0Si0U
Absolutely delighted to be offered this KRUK/MRC clinical training fellowship! I'll be exploring why cysts develop and novel therapeutics in ADPKD. Can't wait to get started! @Ong_Lab#ADPKD@PKDCharity@The_MRC
No. 3, Intraflagellar Transport 140 "Monoallelic IFT140 pathogenic variants are an important cause of an autosomal dominant polycystic kidney-spectrum phenotype" @Ong_Lab@johnasayer https://t.co/tqZ3mkSR9L https://t.co/LJtUbkWvis
As a community we are devastated by the loss of our dear friend, phenomenal colleague & inspirational leader, Donal O’Donoghue.
With Donal’s family’s support we have opened an online memorial page with @RCPLondon so we may all share memories & photos.
https://t.co/hVdaExehZ1
Excited to announced a 4 year fully funded #PhDposition at my lab to study the intriguing RNA binding proteins of kidney and vascular disease. Deadline 25th of Jan! @FindAPhD @ShefUni_IICD @sheffielduni Check it out here: https://t.co/UsMqEMjwRE